Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
TSE:4883
Price:
77 JPY
Updated:
Apr 30, 2024
Modalis Therapeutics Corp
Cash from Investing Activities
|
Modalis Therapeutics Corp
Cash from Investing Activities Peer Comparison
Comparables:
2160
4587
4974
J
7774
S
4599
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Modalis Therapeutics Corp
TSE:4883
|
Cash from Investing Activities
-¥39.7m
|
CAGR 3-Years
64%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Cash from Investing Activities
-¥6.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-42%
|
|
|
PeptiDream Inc
TSE:4587
|
Cash from Investing Activities
¥1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Cash from Investing Activities
-¥8.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
5%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Cash from Investing Activities
¥1B
|
CAGR 3-Years
101%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
S
|
StemRIM Inc
TSE:4599
|
Cash from Investing Activities
-¥344k
|
CAGR 3-Years
87%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Cash from Investing Activities?
Cash from Investing Activities
-39.7m
JPY
-39.7m
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Cash from Investing Activities amounts to -39.7m JPY.
What is Modalis Therapeutics Corp's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-42%
-42%
Over the last year, the Cash from Investing Activities growth was 79%. The average annual Cash from Investing Activities growth rates for Modalis Therapeutics Corp have been 64% over the past three years , -42% over the past five years .
You don't have any saved screeners yet
